Page last updated: 2024-09-04

rhodioloside and 9,10-dimethyl-1,2-benzanthracene

rhodioloside has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies

Compound Research Comparison

Studies (rhodioloside)	Trials (rhodioloside)	Recent Studies (post-2010) (rhodioloside)	Studies (9,10-dimethyl-1,2-benzanthracene)	Trials (9,10-dimethyl-1,2-benzanthracene)	Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene)
621	2	519	6,010	10	772

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kong, YH; Xu, SP	1

Other Studies

1 other study(ies) available for rhodioloside and 9,10-dimethyl-1,2-benzanthracene

Article	Year
Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis. Oncology reports, 2018, Volume: 39, Issue:6 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Cytokines; Drug Administration Schedule; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Phenols; Random Allocation; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2018

Article

Year

Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.

Oncology reports, 2018, Volume: 39, Issue:6

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Cytokines; Drug Administration Schedule; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Phenols; Random Allocation; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2018